PATENT CLAIM ANALYSIS

Application Number: 15887388
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "357000"]

Abstract:
The present disclosure relates to a pharmaceutical composition comprising as active substance betahistine or a pharmaceutically acceptable salt thereof, for use in the treatment of otological or neurological disorders in a human subject by intranasal application.

Claim (Index 69):
The pharmaceutical composition of  claim 60 , further comprising one or more moisturizing agent selected from the group consisting of glycerin, ethylene glycol, propylene glycol, propylene glycol 400, hexalene glycol, butylene glycol, dextrose, glyceryl triacetate, polydextrose, glycerol, glyceryl triacetate, sorbitol, mannitol, and combinations thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13747367', '14966301', '12221333', '15866787', '15564824']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7765553648656376
- 35 USC 102 Novelty (BERT): 0.5221724170062416
- Combined Prediction Score: 0.751117070079698
- Mean Citation Score: 280.87664200000006
- Max Citation Score: 304.8288
- Similarity Product: 175.25411738891603

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test